NCT01902680View on ClinicalTrials.gov

Phase II Study of Feasibility of Focal Therapy for Prostate Cancer of Good Prognosis With Permanent I125 Localized Implant.

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 23, 2013

Primary Completion Date

July 7, 2016

Study Completion Date

June 6, 2017

Conditions
Localized Prostate Cancer
Interventions
RADIATION

Focal brachytherapy

Focal brachytherapy with permanent I125 localized implant.

Trial Locations (1)

31059

Institut Claudius REGAUD, Toulouse

All Listed Sponsors
lead

Institut Claudius Regaud

OTHER

NCT01902680 - Phase II Study of Feasibility of Focal Therapy for Prostate Cancer of Good Prognosis With Permanent I125 Localized Implant. | Biotech Hunter | Biotech Hunter